*Chaitra Sathyaprakash1, China Tatebori1, Reiko Terada1, Katsuhiko Kunitake1, Daisuke Kawauchi2, Momoko Watanabe3, Mariko Taniguchi-Ikeda4, Hideya Sakaguchi5, Yoshitsugu Aoki1
(1. Department of Molecular Therapy, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 2. Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 3. Department of Anatomy & Neurobiology, Sue & Bill Gross Stem Cell Research Center, School of Medicine, University of California, Irvine, Irvine, CA, USA, 4. Department of Clinical Genetics, Fujita Health University Hospital, Toyoake, Aichi, Japan, 5. BDR-Otsuka Pharmaceutical Collaboration Center, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan)
Keywords:Brain Organoids, iPSC model, DMD, Cognitive Disorders